Organigram reported $80.1M Q4 2025 net revenue and $259.2M for fiscal 2025, driven by recreational and international cannabis sales despite ongoing net losses.
Trending
- Massachusetts May Legalize Medical Cannabis Access for Out-of-State Patients
- DEA Warns Medical Marijuana Businesses To Only Obtain Products From Federally Registered Companies
- Nevada Lawmakers Consider Cannabis Industry Tax Reforms
- Nearly 7,000 Marijuana Businesses Have Applied For Federal Protections Under Trump’s Rescheduling Move, New DEA List Shows
- DEA Says Trump’s Marijuana Rescheduling Move Isn’t Weakened By Federal Watchdog Report That Found ‘Gaps’ In Process
- New York Governor Guts Marijuana Worker Minimum Wage Bill At Industry’s Request
- Michigan GOP Lieutenant Governor Candidate Files Bill To Suspend Marijuana Tax Increase
- Iowa GOP Governor Candidate Has Family Members Who Benefit From Medical Marijuana, But He Opposes ‘Full Legalization’
